Lindbrook Capital, LLC Pfizer Inc Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Lindbrook Capital, LLC holds 61,431 shares of PFE stock, worth $1.64 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

61,431

Previous 69,978 12.21%

Holding current value

$1.64 Million

Previous $1.96 Million 9.2%

% of portfolio

0.15%

Previous 0.19%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$27.7 - $31.39 $236,751 - $268,290	-8,547 Reduced 12.21%	61,431 $1.78 Million
Q2 2024 Jul 31, 2024	BUY	$25.26 - $29.6 $182,831 - $214,244	7,238 Added 11.54%	69,978 $1.96 Million
Q1 2024 Apr 25, 2024	BUY	$25.89 - $29.73 $38,886 - $44,654	1,502 Added 2.45%	62,740 $1.74 Million
Q4 2023 Jan 31, 2024	SELL	$26.13 - $33.94 $372,666 - $484,052	-14,262 Reduced 18.89%	61,238 $1.76 Million
Q3 2023 Oct 25, 2023	SELL	$32.09 - $37.51 $146,619 - $171,383	-4,569 Reduced 5.71%	75,500 $2.5 Million
Q2 2023 Jul 28, 2023	BUY	$36.12 - $41.79 $69,169 - $80,027	1,915 Added 2.45%	80,069 $2.94 Million
Q1 2023 Apr 26, 2023	SELL	$39.39 - $51.28 $72,083 - $93,842	-1,830 Reduced 2.29%	78,154 $3.19 Million
Q4 2022 Jan 24, 2023	BUY	$41.75 - $54.5 $220,648 - $288,032	5,285 Added 7.08%	79,984 $0
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $86,032 - $105,023	1,966 Added 2.7%	74,699 $3.27 Million
Q2 2022 Aug 01, 2022	BUY	$46.53 - $55.17 $211,897 - $251,244	4,554 Added 6.68%	72,733 $3.81 Million
Q1 2022 Apr 21, 2022	BUY	$45.75 - $56.69 $114,558 - $141,951	2,504 Added 3.81%	68,179 $3.53 Million
Q4 2021 Jan 18, 2022	BUY	$41.32 - $61.25 $2.4 Million - $3.56 Million	58,083 Added 765.06%	65,675 $3.88 Million
Q3 2021 Nov 05, 2021	SELL	$39.25 - $50.42 $43,881 - $56,369	-1,118 Reduced 12.84%	7,592 $327,000
Q2 2021 Jul 27, 2021	SELL	$35.91 - $40.68 $1,005 - $1,139	-28 Reduced 0.32%	8,710 $341,000
Q1 2021 Apr 28, 2021	SELL	$33.49 - $37.77 $81,548 - $91,969	-2,435 Reduced 21.79%	8,738 $317,000
Q4 2020 Jan 27, 2021	BUY	$33.47 - $42.56 $24,633 - $31,324	736 Added 7.05%	11,173 $411,000
Q3 2020 Nov 03, 2020	SELL	$31.75 - $37.25 $105,187 - $123,409	-3,313 Reduced 24.09%	10,437 $383,000
Q2 2020 Jul 27, 2020	BUY	$30.12 - $36.54 $65,089 - $78,962	2,161 Added 18.65%	13,750 $450,000
Q1 2020 Apr 22, 2020	SELL	$27.03 - $38.62 $84,793 - $121,150	-3,137 Reduced 21.3%	11,589 $378,000
Q4 2019 Jan 27, 2020	BUY	$32.92 - $37.36 $27,455 - $31,158	834 Added 6.0%	14,726 $577,000
Q3 2019 Oct 31, 2019	SELL	$32.49 - $42.13 $45,453 - $58,939	-1,399 Reduced 9.15%	13,892 $499,000
Q2 2019 Jul 24, 2019	SELL	$36.98 - $41.52 $59,537 - $66,847	-1,610 Reduced 9.53%	15,291 $662,000
Q1 2019 Apr 23, 2019	SELL	$37.5 - $41.2 $45,562 - $50,058	-1,215 Reduced 6.71%	16,901 $717,000
Q4 2018 Feb 07, 2019	BUY	$38.47 - $43.86 $696,922 - $794,567	18,116 New	18,116 $790,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Pfizer Inc Transaction History